A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma

Clinical trial NCT00389090 · TERMINATED

Trial details

NCT number: NCT00389090
Sponsor: Keryx / AOI Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioma Astrocytoma Oligodendroglioma Oligoastrocytoma

Start date: 2006-10-01
Primary completion: 2008-06-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.